drugset / Trial / NCT04232306

Liposomal Bupivacaine + Bupivacaine vs. Bupivacaine Alone on Opioid Use After Elective c/Section

NCT04232306 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the effectiveness of local wound infiltration of EXPAREL® (liposomal bupivacaine) with bupivacaine HCl compared to active control with bupivacaine HCl alone following elective primary or repeat cesarean delivery with spinal anesthesia.

Timeline

Start
2024-03
Primary completion
2025-12
Completion
2025-12

Outcome

Outcome not reported

Stopped: “Lack of resources to continue.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified — Other

Indications

No indication recorded.